These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 22089066)

  • 1. Hyperparathyroidism: primary or secondary disease?
    Cordellat IM
    Reumatol Clin; 2012; 8(5):287-91. PubMed ID: 22089066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic evaluation and differential diagnosis of primary hyperparathyroidism].
    Quesada Gómez JM
    Endocrinol Nutr; 2009 Apr; 56 Suppl 1():14-9. PubMed ID: 19627756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Normocalcemic primary hyperparathyroidism: a growing problem].
    Martínez Díaz-Guerra G; Guadalix Iglesias S; Hawkins Carranza F
    Med Clin (Barc); 2013 Aug; 141(3):125-9. PubMed ID: 23199831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary hyperparathyroidism presenting as a palatal and mandibular brown tumor.
    Sutbeyaz Y; Yoruk O; Bilen H; Gursan N
    J Craniofac Surg; 2009 Nov; 20(6):2101-4. PubMed ID: 19884850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
    Yendt ER; Kovacs KA; Jones G
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid disorders.
    Michels TC; Kelly KM
    Am Fam Physician; 2013 Aug; 88(4):249-57. PubMed ID: 23944728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
    Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary hyperparathyroidism: clinical symptoms, diagnostic significance and localisation--a retrospective analysis].
    von Breitenbuch P; Iesalnieks I; Piso P; Schlitt HJ; Agha A
    Zentralbl Chir; 2007 Dec; 132(6):497-503. PubMed ID: 18098076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of hypercalcemia in relation to hyperparathyroidism.
    Pellitteri PK
    Otolaryngol Clin North Am; 2010 Apr; 43(2):389-97, x. PubMed ID: 20510722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hyperparathyroidism in pediatric patients.
    Kollars J; Zarroug AE; van Heerden J; Lteif A; Stavlo P; Suarez L; Moir C; Ishitani M; Rodeberg D
    Pediatrics; 2005 Apr; 115(4):974-80. PubMed ID: 15805373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D and primary hyperparathyroidism (PHPT).
    Souberbielle JC; Bienaimé F; Cavalier E; Cormier C
    Ann Endocrinol (Paris); 2012 Jun; 73(3):165-9. PubMed ID: 22677209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary hyperparathyroidism.
    Oberger Marques JV; Moreira CA
    Best Pract Res Clin Rheumatol; 2020 Jun; 34(3):101514. PubMed ID: 32336576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of hypercalcemia.
    Lafferty FW
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S51-9; discussion S61. PubMed ID: 1763670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can biochemical abnormalities predict symptomatology in patients with primary hyperparathyroidism?
    Bargren AE; Repplinger D; Chen H; Sippel RS
    J Am Coll Surg; 2011 Sep; 213(3):410-4. PubMed ID: 21723154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic and hereditary primary hyperparathyroidism.
    Pepe J; Cipriani C; Pilotto R; De Lucia F; Castro C; Lenge L; Russo S; Guarnieri V; Scillitani A; Carnevale V; D'Erasmo E; Romagnoli E; Minisola S
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):40-4. PubMed ID: 21985979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced parathyroid hormone-stimulated 1,25-dihydroxyvitamin d production in vitamin d sufficient postmenoposual women with low bone mass and idiopathic secondary hyperparathyroidism.
    Streeten EA; Rogstad AS; Flammer KM; Zarbalian K; Ryan K; Horwitz M; Holick MF; Shelton J
    Endocr Pract; 2013; 19(1):91-9. PubMed ID: 23186957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Devastating skeletal effects of delayed diagnosis of complicated primary hyperparathyroidism because of ectopic adenoma.
    Souza ER; Scrignoli JA; Bezerra FC; Ribeiro SL; Passos LF
    J Clin Rheumatol; 2008 Oct; 14(5):281-4. PubMed ID: 18824925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary hyperparathyroidism].
    Carnevale V; Romagnoli E; Pipino M; Scillitani A; D'Erasmo E; Minisola S; Mazzuoli G
    Clin Ter; 2005; 156(5):211-26. PubMed ID: 16382970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.